1. Home
  2. OVBC vs VERU Comparison

OVBC vs VERU Comparison

Compare OVBC & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

N/A

Current Price

$42.26

Market Cap

188.7M

Sector

Finance

ML Signal

N/A

Logo Veru Inc.

VERU

Veru Inc.

N/A

Current Price

$2.32

Market Cap

36.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OVBC
VERU
Founded
1872
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.7M
36.8M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
OVBC
VERU
Price
$42.26
$2.32
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$22.50
AVG Volume (30 Days)
8.9K
49.2K
Earning Date
04-24-2026
05-07-2026
Dividend Yield
2.26%
N/A
EPS Growth
42.67
N/A
EPS
3.31
N/A
Revenue
N/A
$16,296,958.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.75
$0.36
52 Week High
$44.80
$4.59

Technical Indicators

Market Signals
Indicator
OVBC
VERU
Relative Strength Index (RSI) 52.26 41.21
Support Level $34.53 $2.15
Resistance Level $44.73 $2.70
Average True Range (ATR) 1.25 0.11
MACD -0.06 -0.02
Stochastic Oscillator 71.23 23.53

Price Performance

Historical Comparison
OVBC
VERU

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services within Southeastern Ohio as well as western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers and other standard banking products and services.

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Share on Social Networks: